Csenge Advisory Group Has $1.19 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Csenge Advisory Group decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,972 shares of the company’s stock after selling 104 shares during the period. Csenge Advisory Group’s holdings in HCA Healthcare were worth $1,192,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Allworth Financial LP raised its holdings in shares of HCA Healthcare by 24.2% in the fourth quarter. Allworth Financial LP now owns 734 shares of the company’s stock valued at $234,000 after purchasing an additional 143 shares during the last quarter. Principal Securities Inc. raised its holdings in shares of HCA Healthcare by 22.5% in the fourth quarter. Principal Securities Inc. now owns 2,378 shares of the company’s stock valued at $714,000 after purchasing an additional 436 shares during the last quarter. ABC Arbitrage SA purchased a new stake in HCA Healthcare during the fourth quarter worth about $1,511,000. V Square Quantitative Management LLC increased its holdings in HCA Healthcare by 2.3% during the fourth quarter. V Square Quantitative Management LLC now owns 3,826 shares of the company’s stock worth $1,148,000 after buying an additional 85 shares during the last quarter. Finally, Manchester Financial Inc. increased its holdings in HCA Healthcare by 10.2% during the fourth quarter. Manchester Financial Inc. now owns 2,422 shares of the company’s stock worth $727,000 after buying an additional 225 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 1.8 %

HCA stock opened at $316.18 on Monday. The company has a market capitalization of $80.09 billion, a PE ratio of 14.39, a price-to-earnings-growth ratio of 1.11 and a beta of 1.64. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company’s 50 day moving average price is $313.23 and its two-hundred day moving average price is $352.19. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the firm earned $5.90 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.91%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. HCA Healthcare’s payout ratio is presently 12.02%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on HCA. Oppenheimer raised their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. Truist Financial cut their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Royal Bank of Canada cut their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. TD Cowen cut their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Finally, Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.